Patients with elevated IL-6 baseline levels had greater response to sarilumab compared with MTX or adalimumab. #L08 https://t.co/uxMOSD2B1E @RheumNow #ACR18
Links:
Oct-25-2018
Search for Terms or Answers
Search for Terms or Answers
Links:
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
